Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of FluMist® Compared With Trivalent Inactivated Vaccine (TIV) in Children 12 to <36 Months of Age

NCT00461981 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00461981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00461981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of FluMist® Compared With Trivalent Inactivated Vaccine (TIV) in Children 12 to <36 Months of Age
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
February 29, 2008
Enrollment
101 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

influenza vaccine